Venetoclax/decitabine for a pediatric patient with chronic myelomonocytic leukemia
Chronic myelomonocytic leukemia (CMML) is a myelodysplastic syndrome (MDS)/myeloproliferative disorder most commonly seen in the elderly. We describe an adolescent with monosomy 7 CMML presenting as central diabetes insipidus (DI), who was treated with venetoclax and decitabine as a bridge to hemato...
Saved in:
Published in | Pediatric blood & cancer Vol. 68; no. 3; pp. e28865 - n/a |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wiley Subscription Services, Inc
01.03.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Chronic myelomonocytic leukemia (CMML) is a myelodysplastic syndrome (MDS)/myeloproliferative disorder most commonly seen in the elderly. We describe an adolescent with monosomy 7 CMML presenting as central diabetes insipidus (DI), who was treated with venetoclax and decitabine as a bridge to hematopoietic stem cell transplantation (HSCT). Central DI is a rare manifestation of monosomy 7‐associated MDS including CMML, itself a rare manifestation of GATA2 deficiency, particularly in children. Venetoclax/decitabine was effective for treatment of CMML as a bridge to HSCT. |
---|---|
Bibliography: | ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 AUTHOR CONTRIBUTIONS John C. Molina, Julie M. Asare, and Nirali N. Shah wrote the first draft of this manuscript. John C. Molina, Julie M. Asare, Rebecca Persky, Alison M. Boyce, Steven M. Holland, Dennis Hickstein, and Nirali N. Shah all provided patient care. Katerine R. Calvo provided pathology expertise, and Dima A. Hammoud provided radiology expertise. Robert R. West and Laura Tuschong genotyped and tracked mutations. |
ISSN: | 1545-5009 1545-5017 |
DOI: | 10.1002/pbc.28865 |